Straits Times Index
3,183.19 +28.50 (+0.90%) Nikkei
38,005.58 +43.78 (+0.12%) Hang Seng
16,371.03 +119.19 (+0.73%) FTSE 100
7,847.99 +27.63 (+0.35%) Bitcoin USD
61,506.73 -2,346.70 (-3.68%) CMC Crypto 200
885.54 0.00 (0.00%)
MannKind Corporation (MNKD)
After hours:
- GlobeNewswire
MannKind Repays Certain Debt Obligations
Credit and security agreement with MidCap Financial Trust repaid in full for approximately $31.6 millionConvertible note issued to Mann Group LLC repaid in exchange for 1.5 million shares of common stock and approximately $8.9 millionTotal debt reduced since December 31, 2023 is approximately $41.8 million DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled thera
- Simply Wall St.
MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns
Key Insights Given the large stake in the stock by institutions, MannKind's stock price might be vulnerable to their...
- Zacks
Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
